Both CD4+ and CD8+ CAR-T cells significantly increased the tumor response score with neuroblastoma stimulation (P < 2.2 × 10−16 by two-sided t-test) (Fig. 5B,C). The gene discussed is CD4; the disease is neuroblastoma.